Close Menu

GenapSys

NEW YORK (GenomeWeb News) – The National Human Genome Research Institute said today that it has pumped $19 million into new research and development projects that seek to bring down the costs of DNA sequencing.

By Julia Karow
GenapSys of Menlo Park, Calif., is developing a DNA sequencing instrument that will be based on label-free nanosensor array technology.

Cofactor Genomics has hired Don Henricksen as its North American sales director. Henricksen joins Cofactor after 16 years at PerkinElmer, most recently as a regional manager in the company's bio-discovery division.

Companies developing DNA sequencing and related technologies, as well as firms working on sequencing-based genetic tests, were among almost 3,000 small biotechs who received a total of $1 billion in grants and tax credits under the QTDP program.

Pages

The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.

Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.

Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.

In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.